Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Times Interest Earned (2020 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Times Interest Earned for 5 consecutive years, with -$352.97 as the latest value for Q3 2024.

  • Quarterly Times Interest Earned fell 14.7% to -$352.97 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$2692.9 through Jun 2025, down 780.36% year-over-year, with the annual reading at -$438.04 for FY2024, 40.67% down from the prior year.
  • Times Interest Earned for Q3 2024 was -$352.97 at Whitehawk Therapeutics, down from -$268.69 in the prior quarter.
  • The five-year high for Times Interest Earned was -$11.63 in Q3 2020, with the low at -$556.12 in Q3 2021.
  • Average Times Interest Earned over 5 years is -$260.74, with a median of -$284.91 recorded in 2023.
  • The sharpest move saw Times Interest Earned crashed 4682.26% in 2021, then soared 53.38% in 2022.
  • Over 5 years, Times Interest Earned stood at -$11.63 in 2020, then crashed by 2305.55% to -$279.74 in 2021, then rose by 2.97% to -$271.44 in 2022, then fell by 14.49% to -$310.77 in 2023, then dropped by 13.58% to -$352.97 in 2024.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$352.97, -$268.69, and -$336.41 for Q3 2024, Q2 2024, and Q1 2024 respectively.